Literature DB >> 11494337

Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.

I Leav1, K H Schelling, J Y Adams, F B Merk, J Alroy.   

Abstract

BACKGROUND: The canine prostate has often been proposed as a model for abnormal growth of the human gland. Hyperplasia of the prostate is common in aging men and has been estimated to be present in 100% of old intact dogs. While prostatic carcinoma is common in older men, it appears to be rare in dogs and unlike the disease in humans, it occurs with relatively high frequency in castrated animals. Since basal cells are thought to be key participants in normal and abnormal growth of the human gland, we used immunohistochemistry to investigate the role that they may play in canine prostatic development, the evolution of hyperplasia and carcinoma, and the effects of sex hormones on these cells.
METHODS: Prostate specimens were obtained at autopsy from seven sexually immature dogs, autopsy and biopsy samples from 14 sexually mature intact animals, from four castrates, and from19 dogs with prostatic carcinoma. In addition, we also studied the prostates from two intact dogs treated with 5alpha-dihydrotestosterone (DHT) for 6 months and two castrated dogs that were subsequently treated with 5alpha-androstane-3alpha diol and estradiol-17alpha, as well as specimens from two sexually ablated animals given DHT for 2 weeks. All specimens were immunostained for high molecular weight cytokeratin (HMC), pancytokeratin, androgen receptor (AR), and the proliferative marker KI-67.
RESULTS: We find that basal cells are the major proliferative cell type in the neonatal and adult canine prostate and that the expression of HMC staining, which defines these cells, may be regulated by androgens. In the adult gland, ductal basal cells formed a contiguous layer, whereas those lining acini were discontinuous. Populations of both basal cell types were variably AR positive, but while HMC immunostaining was abolished in acinar cells following long-term castration, staining remained in ductal cell counterparts. Paralleling the histological development of hyperplasia, the acinar basal cell population increased with age and were the major cell type that expressed KI-67. In contrast, ductal basal cell populations did not expand in the prostates of older dogs and were seldom positively stained for KI-67. The numbers of HMC and KI-67-stained acinar basal cells were dramatically increased in the prostates of intact dogs treated with DHT when compared with glands of untreated controls. This was not the case with ductal basal cells. Androgens given alone or together with estrogen to castrated dogs induced widespread HMC and KI-67 immunostaining in both populations of basal cells. In addition, our results indicate that the majority of canine prostatic carcinomas likely arise exclusively from ductal epithelium. Only one of the 19 cases of carcinoma contained cells that expressed AR, which suggests that androgens may not be required for the initiation or progression of these cancers.
CONCLUSIONS: Our findings indicate that two biologically distinct populations of basal cells may exist in the canine prostate. In this regard, the age-related expansion of proliferating acinar basal cell populations, probably mediated by sex steroids, is a key factor in the pathogenesis of canine prostatic hyperplasia. Additionally, we find that prostatic carcinoma in the dog likely arises from ductal cells. Taken together, these findings may indicate that canine acinar basal cells and ductal epithelium have separate susceptibilities to factors that promote hyperplastic or neoplastic development. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494337     DOI: 10.1002/pros.1100

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

Review 1.  Animal models of bone metastasis.

Authors:  Thomas J Rosol; Sarah H Tannehill-Gregg; Stephanie Corn; Abraham Schneider; Laurie K McCauley
Journal:  Cancer Treat Res       Date:  2004

2.  Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity.

Authors:  Silvana G P Campos; Bianca F Gonçalves; Wellerson R Scarano; Lara S Corradi; Fernanda C A Santos; Ana M G Custodio; Patricia S L Vilamaior; Rejane M Góes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

3.  Canine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivo.

Authors:  Jessica K Simmons; Wessel P Dirksen; Blake E Hildreth; Carlee Dorr; Christina Williams; Rachael Thomas; Matthew Breen; Ramiro E Toribio; Thomas J Rosol
Journal:  Prostate       Date:  2014-07-07       Impact factor: 4.104

Review 4.  A Review on Canine and Feline Prostate Pathology.

Authors:  Chiara Palmieri; Carlos Eduardo Fonseca-Alves; Renee Laufer-Amorim
Journal:  Front Vet Sci       Date:  2022-05-26

5.  Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.

Authors:  Simone de Brot; Jennifer Lothion-Roy; Llorenç Grau-Roma; Emily White; Franco Guscetti; Mark A Rubin; Nigel P Mongan
Journal:  Vet Comp Oncol       Date:  2021-05-18       Impact factor: 2.385

6.  Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258.

Authors:  Melani A M Fork; Hugo Murua Escobar; Jan T Soller; Katharina A Sterenczak; Saskia Willenbrock; Susanne Winkler; Martina Dorsch; Nicola Reimann-Berg; Hans J Hedrich; Jörn Bullerdiek; Ingo Nolte
Journal:  BMC Cancer       Date:  2008-08-15       Impact factor: 4.430

7.  Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.

Authors:  Raffaella Leoci; Giulio Aiudi; Fabio Silvestre; Elaine Lissner; Giovanni Michele Lacalandra
Journal:  Prostate       Date:  2014-06-09       Impact factor: 4.104

Review 8.  Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models.

Authors:  Fei Sun; Claudia Báez-Díaz; Francisco Miguel Sánchez-Margallo
Journal:  Transl Androl Urol       Date:  2017-06

Review 9.  Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models.

Authors:  Fei Sun; Claudia Báez-Díaz; Francisco Miguel Sánchez-Margallo
Journal:  Transl Androl Urol       Date:  2017-06

Review 10.  Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?

Authors:  Magdalena Schrank; Stefano Romagnoli
Journal:  Animals (Basel)       Date:  2020-01-05       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.